Severe neutropenia secondary to piperacillin/tazobactam therapy

Indian Journal of Pharmacology

Volumn 37, Issue 3, 2005, Pages 192-193

  Khan, F ^a  

^a HAMAD GENERAL HOSPITAL   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANAMNESIS; ARTICLE; BONE MARROW EXAMINATION; BONE MARROW SUPPRESSION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; FEVER; HUMAN; LABORATORY TEST; LEUKOPENIA; MALE; MEDICAL EXAMINATION; NEUTROPENIA; NEUTROPHIL; PLEURA EFFUSION;

EID: 21244439925     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.16222     Document Type: Article

References (11)

1. Young M, Plosker GL: Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections. Pharmacoeconomics 2001;19:1135-75.
2. Bryson HM, Brogden RN. Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1994;47:506-35.
3. Kaucers A, Crowe SM, Grayson ML, Hoy JF, editors. The use of antibiotics: A clinical review of antibacterial, antifungal and antiviral drugs. Oxford: Butterworth Heinemann 1997.
4. Bressler, RB, Huston DP. Piperacillin-induced anemia and leucopenia. South Med J 1986;79:255-6.
5. Wilson C, Greenhood G, Remington JS, Vosti KL. Neutropenia after consecutive treatment courses with nafcillin and piperacillin. Lancet 1979;1:1150.
6. Reichardt P, Handrick W, Linke A, Schille R, Kiess W. Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment - a retrospective analysis in 38 children with cystic fibrosis. Infection 1999;27:355-6.
7. Ruiz-Irastorza G, Barreiro G, Aguirre C. Reversible bone marrow depression by high-dose piperacillin/tazobactam. Br J Haematol 1996;95:611-2.
8. Gerber L, Wing EJ. Life-threatening neutropenia secondary to piperacillin/tazobactam therapy. Clin Infec Dis 1995;21:1047-8.
9. Neftel KA, Hauser SP, Müller MR. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J Infect Dis 1985;152:90-8.
10. Singh N, Yu VL, Mieles LA, Wagener MM. Beta-lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Am J Med 1993;94:251-6.
11. Frangi D, Gardinali M. Abrupt complement activation and transient neutropenia in patients with acute myocardial infarction treated with streptokinase. Circulation 1994;89:76-80.